Palisade Bio Inc (PALI): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 03.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 10,222 US Dollar | 2 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 174.270.558 | 19,17 | 16,29 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Palisade Bio Inc
Mitarbeiter 14
Handelsplatz NASDAQ
Ticker Symbol PALI
IPO Datum 2006-12-20
Adresse 4600 South Syracuse Street, Denver, CO, United States, 80237
Webseite https://www.palisadebio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. J. D. Finley | CEO, CFO & Director |
| 2 | Dr. Mitchell Lawrence Jones M.D., Ph.D. | President & Chief Medical Officer |
| 3 | Mr. Ramesh C. Donthamsetty | Head of Corporate Development & Investor Relations |
| 4 | Dr. Joerg Heyer Ph.D. | Head of Translational Science & Medicine |
| 5 | Dr. James Izanec M.D. | VP & Head of Clinical Development |
| 6 | Mr. Daniel J. Larkins | Head of Global Regulatory Affairs |
| 7 | Mr. Adarsh Patel M.B.A., M.S. | Head of Chemistry, Manufacturing & Controls |
| 8 | Ms. Dawn Louro | VP & Head of Clinical Operations |
| 9 | Mr. Ryker Willie | Senior VP of Finance & Corporate Controller |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Soleus Capital Management, L.P. | 7,52% | 26,07 Mio. USD |
| 2 | Ameriprise Financial Inc | 6,62% | 22,97 Mio. USD |
| 3 | B Group, Inc | 6,57% | 22,78 Mio. USD |
| 4 | HHG PLC | 6,15% | 21,33 Mio. USD |
| 5 | Octagon Capital Advisors LP | 5,91% | 20,51 Mio. USD |
| 6 | Perceptive Advisors LLC | 5,14% | 17,82 Mio. USD |
| 7 | COMMODORE CAPITAL LP | 4,13% | 14,33 Mio. USD |
| 8 | RA Capital Management, LLC | 4,10% | 14,22 Mio. USD |
| 9 | Franklin Templeton Inc | 3,33% | 11,54 Mio. USD |
| 10 | The Goldman Sachs Group Inc | 3,09% | 10,72 Mio. USD |
| 11 | Boxer Capital Management, LLC | 2,76% | 9,58 Mio. USD |
| 12 | Morgan Stanley - Brokerage Accounts | 2,62% | 9,08 Mio. USD |
| 13 | Adage Capital Partners Gp LLC | 2,59% | 8,98 Mio. USD |
| 14 | Eversept Partners, LP | 2,41% | 8,35 Mio. USD |
| 15 | Wellington Management Company LLP | 2,13% | 7,39 Mio. USD |
| 16 | Balyasny Asset Management LLC | 1,88% | 6,53 Mio. USD |
| 17 | Federated Hermes Inc | 1,80% | 6,26 Mio. USD |
| 18 | Squadron Capital Management LLC | 1,73% | 5,99 Mio. USD |
| 19 | Marshall Wace Asset Management Ltd | 1,58% | 5,50 Mio. USD |
| 20 | Propel Bio Management LLC | 1,49% | 5,15 Mio. USD |